Fersiynau electronig

Dogfennau

Dangosydd eitem ddigidol (DOI)

  • C. G. Walklin
    Motor Nerve Clinic, Academic Neurosciences Centre, King’s College Hospital NHS Foundation Trust
  • Hannah M.L Young
    Leicester General Hospital
  • E. Asghari
    Guy’s and St Thomas’ NHS Trust
  • S. Bhandari
    Hull University Teaching Hospitals NHS
  • R. E. Billany
  • N. Bishop
  • K. Bramham
  • J. Briggs
    Motor Nerve Clinic, Academic Neurosciences Centre, King’s College Hospital NHS Foundation Trust
  • J. O. Burton
  • J. Campbell
  • E. M. Castle
  • J. Chilcot
  • N. Cooper
  • V. Deelchand
  • M. P.M Graham-Brown
  • A. Hamilton
  • M. Jesky
  • P. A. Kalra
  • P. Koufaki
  • K. McCafferty
  • A. C. Nixon
  • H. Noble
  • Z. L. Saynor
  • C. Sothinathan
  • M. W. Taal
  • J. Tollitt
  • D.C Wheeler
  • T. J. Wilkinson
  • J.H Macdonald
    King's College London
  • S. A. Greenwood
Background
Physical activity and emotional self-management has the potential to enhance health-related quality of life (HRQoL), but few people with chronic kidney disease (CKD) have access to resources and support. The Kidney BEAM trial aims to evaluate whether an evidence-based physical activity and emotional wellbeing self-management programme (Kidney BEAM) leads to improvements in HRQoL in people with CKD.

Methods
This was a prospective, multicentre, randomised waitlist-controlled trial, with health economic analysis and nested qualitative studies. In total, three hundred and four adults with established CKD were recruited from 11 UK kidney units. Participants were randomly assigned to the intervention (Kidney BEAM) or a wait list control group (1:1). The primary outcome was the between-group difference in Kidney Disease Quality of Life (KDQoL) mental component summary score (MCS) at 12 weeks. Secondary outcomes included the KDQoL physical component summary score, kidney-specific scores, fatigue, life participation, depression and anxiety, physical function, clinical chemistry, healthcare utilisation and harms. All outcomes were measured at baseline and 12 weeks, with long-term HRQoL and adherence also collected at six months follow-up. A nested qualitative study explored experience and impact of using Kidney BEAM.

Results
340 participants were randomised to Kidney BEAM (n = 173) and waiting list (n = 167) groups. There were 96 (55%) and 89 (53%) males in the intervention and waiting list groups respectively, and the mean (SD) age was 53 (14) years in both groups. Ethnicity, body mass, CKD stage, and history of diabetes and hypertension were comparable across groups. The mean (SD) of the MCS was similar in both groups, 44.7 (10.8) and 45.9 (10.6) in the intervention and waiting list groups respectively.

Conclusion
Results from this trial will establish whether the Kidney BEAM self management programme is a cost-effective method of enhancing mental and physical wellbeing of people with CKD.

Allweddeiriau

Iaith wreiddiolSaesneg
Rhif yr erthygl122
Nifer y tudalennau17
CyfnodolynBMC Nephrology
Cyfrol24
Rhif y cyfnodolyn1
Dynodwyr Gwrthrych Digidol (DOIs)
StatwsCyhoeddwyd - 2 Mai 2023

Cyfanswm lawlrlwytho

Nid oes data ar gael
Gweld graff cysylltiadau